Efficacy and safety of gastrodin in preventing postoperative delirium following cardiac surgery: a randomized placebo controlled clinical trial.
- 2025-03-11
- RCT
- Critical care (London, England) 29(1)
- Yun-Xiao Bai
- Hui-Liang Wu
- Wan-Li Xie
- Xia Li
- Jing-Jing Han
- Jie Liu
- Shi-Qiang Chen
- Ping Yin
- Nian-Guo Dong
- Qing-Ping Wu
- PubMed: 40069830
- DOI: 10.1186/s13054-025-05331-9
- High evidence
- Clinical
The incidence of in-hospital POCD was 2.9% and 4.0% in the placebo and gastrodin groups, respectively.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 600 mg twice daily